Proscar and Skin hypertrophy - a phase IV clinical study of FDA data

Summary:

Skin hypertrophy is reported as a side effect among people who take Proscar (finasteride), especially for people who are male, 40-49 old, have been taking the drug for 2 - 5 years also take Furosemide, and have Prostatomegaly.

The phase IV clinical study analyzes which people have Skin hypertrophy when taking Proscar. It is created by eHealthMe based on reports of 13,025 people who have side effects when taking Proscar from the FDA, and is updated regularly.

What is Proscar?

Proscar has active ingredients of finasteride. It is often used in prostate examination abnormal. eHealthMe is studying from 13,379 Proscar users. Check the latest studies of Proscar.

What is Skin hypertrophy?

Skin hypertrophy (skin cells enlarges) is found to be associated with 588 drugs and 548 conditions by eHealthMe. Check the latest studies of Skin hypertrophy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

13,025 people reported to have side effects when taking Proscar.
Among them, 16 people (0.12%) have Skin hypertrophy.

Among these 16 people:

How long have people been on Proscar when they have Skin hypertrophy? *

What is the gender of people who have Skin hypertrophy when taking Proscar? *

female: 0.0 %
male: 100 %

What is the age of people who have Skin hypertrophy when taking Proscar? *

What are other drugs people take besides Proscar? *

What are other side effects people have besides Skin hypertrophy? *

Weakness: 11 people, 68.75%
Itching: 11 people, 68.75%
Joint Range Of Motion Decreased (disease of joint movement): 11 people, 68.75%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 11 people, 68.75%
Exercise Tolerance Decreased: 10 people, 62.50%
Muscle Aches (muscle pain): 10 people, 62.50%
Muscle Spasms (muscle contraction): 10 people, 62.50%
Dyspnea (difficult or laboured breathing): 10 people, 62.50%
Gait Disturbance: 10 people, 62.50%
Skin Tightness: 10 people, 62.50%

What are the existing conditions these people have? *

Prostatomegaly (enlargement of the prostate): 2 people, 12.50%
Skin Ulcer: 1 person, 6.25%
Parkinson's Disease: 1 person, 6.25%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 6.25%
Diabetes: 1 person, 6.25%
Blood Pressure Abnormal: 1 person, 6.25%
Anaemia (lack of blood): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Proscar and have Skin hypertrophy?

- Check whether Skin hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Proscar:

Proscar (13,379 reports)

Browse all side effects of Proscar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hypertrophy:

Skin hypertrophy (588 drugs)

Browse all the conditions that are associated with Skin hypertrophy:

Skin hypertrophy (548 conditions)

Related publications that referenced our studies

Fouda AM, Bazeed AM, "Hematuria and Hematospermia Associated with the Use of Finasteride for the Treatment of Androgenic Alopecia: A Case Report", Drug Safety-Case Reports, 2017 Dec .
Fouda AM, Bazeed AM, "Hematuria and Hematospermia Associated with the Use of Finasteride for the Treatment of Androgenic Alopecia: A Case Report", Drug Safety-Case Reports, 2017 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on finasteride (the active ingredients of Proscar) and Proscar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.